Coherus BioSciences (CHRS) - Wutah bathi EPS kuartalan

Simbol resmi perusahaan Coherus BioSciences, Inc. (CHRS)

Coherus Biosciences (CHRS) develops innovative oncology drugs and biosimilars, balancing fierce competition with premium pricing. The quarterly earnings per share trend clearly demonstrates revenue volatility, with the current figure standing at 16.90. Its status as the sole approved PD-1 inhibitor for rare carcinomas strengthens the firm's position, while the expansion of its ecosystem through AI solutions and insurance coverage ensures a steady capture of market share.

Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Coherus BioSciences Inc. (CHRS): kanggo periode 04.07.2022 - 17.11.2026

Rincian analitis perusahaan Coherus Biosciences

Analisis fundamental perusahaan:coherus.com, CHRS
Produk asil prodhuksi Coherus Biosciences

Regulator-approved biosimilars and oncology drugs provide Coherus Biosciences (CHRS) with fundamental stability. This indicator measures the dynamics of net earnings per share, reflecting the actual speed of capital generation. By analyzing the trajectory of quarterly EPS growth, an investor determines the intensity of business scaling. Sharp spikes in the line may indicate temporary factors rather than systemic growth, allowing one to avoid overpaying for the asset ahead of a potential correction.

Analisis perusahaan pesaing

Incyte Corporation (INCY) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan HUTCHMED Corp|NUVB (nuvationbio.com) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan dayonebio.com (DAWN)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Monopar Corp (MNPR)|INBX - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan I-Mab Inc. IMAB|Fennec - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|HRTX - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Nuvectis Pharma, Inc.|CRBP: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham sajroning taun lumaku Cardiff Oncology, Inc. CRDF|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan BYSI|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan BioAtla BCAB|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan LIXT (Lixte Biotechnology)|CTXR (Citius Pharma) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Cellectar Biosciences - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan BLRX (BioLineRx)|Can-Fite BioPharma, Ltd. - Wutah bathi EPS kuartalan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan APRE (aprea.com)|KZIA: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Silexion (SLXN)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan nucana.com|CMRX: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan CYCC|Wutah bathi EPS kuartalan G1 Therapeutics Inc. (GTHX)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Kronos Bio Corp KRON|KTRA (Kintara Therapeutics, Inc.) - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|ONCT: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Portage Biotech Inc